335 related articles for article (PubMed ID: 16125245)
1. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS.
Li G; Liu W; Frenz D
Neurotoxicology; 2006 Jan; 27(1):22-30. PubMed ID: 16125245
[TBL] [Abstract][Full Text] [Related]
2. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
3. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
4. Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice.
Watanabe K; Inai S; Jinnouchi K; Bada S; Hess A; Michel O; Yagi T
Anticancer Res; 2002; 22(6C):4081-5. PubMed ID: 12553036
[TBL] [Abstract][Full Text] [Related]
5. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.
Feghali JG; Liu W; Van De Water TR
Laryngoscope; 2001 Jul; 111(7):1147-55. PubMed ID: 11568534
[TBL] [Abstract][Full Text] [Related]
6. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen protects auditory hair cells from cisplatin-induced free radicals.
Kikkawa YS; Nakagawa T; Taniguchi M; Ito J
Neurosci Lett; 2014 Sep; 579():125-9. PubMed ID: 25064701
[TBL] [Abstract][Full Text] [Related]
8. Chemoprotective effect of a nuclear factor-kappaB inhibitor, pyrrolidine dithiocarbamate, against cisplatin-induced testicular damage in rats.
Ilbey YO; Ozbek E; Simsek A; Cekmen M; Otunctemur A; Somay A
J Androl; 2009; 30(5):505-14. PubMed ID: 19234314
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin does not mitigate cisplatin ototoxicity or nephrotoxicity in adult mice.
Schmitt NC; Rubel EW
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):614-20. PubMed ID: 23884286
[TBL] [Abstract][Full Text] [Related]
10. HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage.
Chen X; Frisina RD; Bowers WJ; Frisina DR; Federoff HJ
Mol Ther; 2001 Jun; 3(6):958-63. PubMed ID: 11407910
[TBL] [Abstract][Full Text] [Related]
11. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
Lynch ED; Gu R; Pierce C; Kil J
Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563
[TBL] [Abstract][Full Text] [Related]
12. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R
J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
[TBL] [Abstract][Full Text] [Related]
14. HSP-70 as a nonspecific early marker in cisplatin ototoxicity.
Ramírez-Camacho R; Citores MJ; Trinidad A; Verdaguer JM; García-Berrocal JR; Marero AM; Puente A; González-García JA; Vargas JA
Acta Otolaryngol; 2007 Jun; 127(6):564-7. PubMed ID: 17503223
[TBL] [Abstract][Full Text] [Related]
15. [Effect of cisplatin on apoptosis of spiral ganglion cell and expression of caspase-3 in mouse cochlea].
Sun WX; Wang AM; Bao CF; Hui LJ; Chang ZJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Aug; 26(3):324-8. PubMed ID: 21038681
[TBL] [Abstract][Full Text] [Related]
16. Supporting cells as a target of cisplatin-induced inner ear damage: therapeutic implications.
Ramírez-Camacho R; García-Berrocal JR; Buján J; Martín-Marero A; Trinidad A
Laryngoscope; 2004 Mar; 114(3):533-7. PubMed ID: 15091230
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
[TBL] [Abstract][Full Text] [Related]
18. Role of inducible nitric oxide synthase expressed by alveolar macrophages in high mobility group box 1--induced acute lung injury.
Ren D; Sun R; Wang S
Inflamm Res; 2006 May; 55(5):207-15. PubMed ID: 16830108
[TBL] [Abstract][Full Text] [Related]
19. Temporal bone histopathology of cisplatin ototoxicity.
Hinojosa R; Riggs LC; Strauss M; Matz GJ
Am J Otol; 1995 Nov; 16(6):731-40. PubMed ID: 8572135
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase inhibitor suppresses the ototoxic side effect of cisplatin in guinea pigs.
Watanabe KI; Hess A; Bloch W; Michel O
Anticancer Drugs; 2000 Jun; 11(5):401-6. PubMed ID: 10912957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
